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By a pulse-chase approach combined with immunoprecipitation, we showed that the newly synthesized precursors of
glycoprotein B (gB), glycoprotein C (gC), and glycoprotein D (gD) of herpes simplex virus type 1 (HSV-1) were associated
with calnexin, a membrane-bound chaperone in the endoplasmic reticulum. Kinetics of association and dissociation was
quite different among the precursors. For the precursors of gC and gD of HSV-1, the maximal association was observed
immediately after the synthesis and they dissociated rapidly with half-times of 25 min for gC and 30 min for gD, respectively.
In contrast, the precursor of gB showed prolonged association with calnexin. Their maximum association was observed 30
min after the synthesis, and thereafter, they dissociated slowly with a half-time of 70 min. The results suggest that, while
glycoproteins that have a rapid processing rate, such as gC and gD of HSV-1, rapidly associate with calnexin and their
association is quite short, those that take much time to be processed to a mature form, such as gB of HSV-1, have prolonged
association kinetics with calnexin. Complete inhibition of the binding of these glycoprotein precursors to calnexin by
tunicamycin or castanospermine indicates the importance of partially trimmed N-linked oligosaccharides for their association.
q 1996 Academic Press, Inc.
Fidelity in the expression of proteins in the cell is en- are known to be encoded by herpes simplex virus type
1 (HSV-1): gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL, and gMsured at many levels from transcription of genes to intra-
cellular transport of the final products. The endoplasmic (11–14). These glycoproteins are the primary inducers
and targets of both humoral and cell-mediated immunereticulum (ER) possesses a so-called ‘‘quality control’’
system acting at the posttranslational level that permits responses in HSV infection (15). In addition, some of the
HSV glycoproteins, such as gC and gE/gI have beenproperly folded and assembled proteins to leave the ER
and proceed to the Golgi complex and beyond. Recent shown to interact with specific components of the im-
studies have suggested that molecular chaperones play mune system, which is thought to be one of the clues
important roles in the quality control system (1, 2). They for HSV to evade the host immune system (16, 17).
transiently recognize and stabilize partially folded inter- Among these, gB, gD, gH, gK, and gL are essential for
mediates or misfolded polypeptides. Calnexin (previously productive infection in cultured cells and thought to have
known as p88 or IP90) was originally identified by virtue an important role for cell fusion as well as for virus entry
of its transient association with the nascent heavy chain into cells (18–21).
of class I major histocompatibility complex molecules Here, we focused on gB, gC, and gD of HSV-1 and
(3, 4). Unlike other chaperones, such as BiP/GRP78 and studied the role of calnexin during their processing.
GRP94, it is an integral membrane protein, with a molecu- Since HSV has the ability to induce rapid shutoff of host
lar mass of approximately 90 kDa for human cells (5). protein synthesis and accelerated decay of cellular
Subsequently, calnexin has been found associated with mRNA, it would be interesting to determine whether the
folding and assembly intermediates of a wide array of cellular quality control system functions well in the syn-
soluble and membrane proteins, including viral glycopro- thesis of HSV glycoproteins in the late period of infection.
teins (6–10). HSV-1 strain KOS and human embryonic lung fibro-
To date at least 11 antigenically distinct glycoproteins blasts (HEL) were used throughout this study. HEL were
propagated in Eagle’s minimal essential medium (MEM)
containing 10% fetal calf serum (FCS) and used between
1 To whom correspondence and reprint requests should be ad-
passages 15 and 25. The virus stock was prepared indressed at Laboratory of Virology, Research Institute for Disease Mech-
Vero cells by infection at a low multiplicity. A polyclonalanism and Control, Nagoya University School of Medicine, 65 Tsurumai-
cho, Showa-ku, Nagoya 466, Japan. Fax: 52-744-2452 Japan. rabbit antiserum against a synthetic peptide correspond-
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FIG. 1. Effect of HSV-1 infection on the amount (A) and synthesis (B) of cellular calnexin. (A) Confluent monolayers of HEL were mock-infected
or infected with HSV-1 strain KOS at a mulitiplicity of 10 PFU per cell. At the indicated times after infection, the cells were lysed and subjected to
SDS –7.5% PAGE . The separated proteins were electrophoretically transferred to a Hybond-PVDF membrane and probed with rabbit anticalnexin
antiserum and HRP-conjugated sheep immunoglobulin F(ab*)2 fragments against rabbit IgG (1:300). The detailed procedures for immunoblotting
have been described elsewhere (23). (B) Confluent monolayers of HEL were mock-infected or infected with HSV-1 strain KOS. At the indicated
times after infection, the cells were labeled for 20 min with [35S]methionine. The cells were lysed under denaturing conditions and the lysates were
immunoprecipitated with anticalnexin. The procedures for immunoprecipitation have been described elsewhere (24). The immunoprecipitates were
analyzed by SDS–7.5% PAGE. NS denotes control with normal rabbit serum. The position of calnexin is indicated. Molecular mass markers are
also shown to the right of the gel (in kilodaltons).
ing to amino acids 487 to 505 of canine calnexin was a with anticalnexin under denaturing conditions. Figure 1B
shows the SDS–PAGE profile of the experiment. Thegenerous gift of J. M. Bergeron (McGill University, Mon-
treal, Canada) (5). The following monoclonal anbibodies band for calnexin migrated was calculated at 102 kDa
in our system, although its molecular mass is reportedwere described elsewhere: M11 against HSV-1 gB
(mouse IgG2a), M14 against HSV-1 gC (mouse IgG2a), to be 90 kDa in the literature (5). The amount of calnexin
synthesized in HSV-1-infected cells decreased immedi-and M1 against HSV-1 gD (mouse IgG1) (22). Casta-
nospermine was purchased from Wako Pure Chemical ately after infection, and the band for newly synthesized
calnexin became undetectable by 12 hr after infection.Industries (Osaka, Japan). The following reagents were
from Sigma Chemical Co. (St. Louis, MO): tunicamycin These results were not inconsistent with those from the
immunoblotting shown in Fig. 1A, since calnexin has aand N-ethylmaleimide (NEM). The procedures for immu-
noprecipitation and immunoblotting have been described relatively prolonged turnover rate (26).
To determine whether there are any HSV-1 proteinselsewhere (23, 24). Generally, immunoprecipitation was
performed under nondenaturing conditions as described transiently associated with calnexin, we compared the
profiles of proteins coprecipitated with calnexin fromelsewhere (10).
We first determined the effect of HSV-1 infection on HSV-1-infected cells with those from mock-infected cells.
Confluent monolayers of HEL were mock-infected or in-the amount of calnexin in infected cells. Confluent mono-
layers of HEL were mock-infected or infected with HSV- fected with HSV-1 for 12 hr, pulsed with [35S]methionine
for 20 min, and subjected to immunoprecipitation with1 strain KOS at a multiplicity of 10 PFU per cell, and at
various times after infection, the cells were subjected to anticalnexin (Fig. 2). When the HSV-1-infected HEL were
lysed immediately after the pulse and subjected to immu-immunoblotting and calnexin was probed with an antical-
nexin antiserum and an HRP-conjugated second anti- noprecipitation under nondenaturing conditions, three
proteins were coprecipitated with anticalnexin, whosebody. As shown in Fig. 1A, the amount of calnexin in
HSV-1-infected cells was almost unaltered up to 24 hr molecular masses were calculated at 128, 107, and 54
kDa (Fig. 2, compare with the lanes for denaturing condi-after infection in comparison with that in uninfected cells.
Since HSV-1 has been known to shut off host protein tions). These were specific for HSV-1-infected HEL, since
they were not precipitated from the lysate of the mock-synthesis (25), we next determined the effect of HSV-1
infection on the synthesis of calnexin. Confluent mono- infected cells or with control serum. Among these, a band
migrating at 107 kDa had almost the same electropho-layers of HEL were mock-infected or infected with HSV-
1 at a multiplicity of 10 PFU per cell. At various times retic mobility as calnexin. However, it was not authentic
calnexin, because the infected cells used in the experi-after infection, the cells were pulsed with [35S]-
methionine, lysed, and subjected to immunoprecipitation ments were radiolabeled after 12 hr of infection, when
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FIG. 2. Association of newly synthesized proteins with calnexin in HSV-1-infected HEL. Confluent monolayers of HEL were mock-infected or
infected with HSV-1 strain KOS. At 12 hr after infection, the cells were labeled for 20 min with [35S]methionine and chased for 6 hr. The cells were
lysed under nondenaturing conditions and subjected to immunoprecipitation with anticalnexin (Cal) or normal rabbit serum (NS). The precipitates
were analyzed by SDS–7.5% PAGE (Nondenaturing). For comparison, the cells were lysed under denaturing conditions and the lysates were
precipitated with anticalnexin (Cal), anti-gB (gB), anti-gC (gC), or anti-gD (gD). The immunoprecipitates were analyzed by SDS–7.5% PAGE and
shown in the same gel (Denaturing). Molecular mass markers are also shown to the right of the gel (in kilodaltons).
synthesis of calnexin was completely shut off by infection jected to first-round immunoprecipitation with antical-
nexin under nondenaturing conditions (Fig. 3, First IP,with HSV-1, and because it was not precipitated from
the infected cell lysate under denaturing conditions (Figs. ND). The associated proteins with calnexin were eluted
with SDS and heat and immunoprecipitated with control1B and 2, the lanes for denaturing conditions). When
the infected cells were chased for 6 hr, these proteins serum or respective monoclonal antibodies. As shown
in Fig. 3 (Sequential IP), the precursors of gB, gC, andprecipitated with anticalnexin disappeared, except the
128-kDa protein, which was still seen as a faint band, gD of HSV-1 were precipitated from the anticalnexin pre-
cipitates obtained from the HSV-1-infected HEL lysateindicating that the association between these proteins
with calnexin was transient. These proteins coprecipi- under nondenaturing conditions, confirming that the au-
thentic precursors of gB, gC, and gD of HSV-1 associatedtated with calnexin were most likely to be the precursors
of gB, gC, and gD of HSV-1, since they had the same with calnexin immediately after their synthesis.
To determine the kinetics of the association betweenelectrophoretic mobilities (Fig. 2, lanes for anti-gB, anti-
gC, and anti-gD precipitates). gB, gC, and gD of HSV-1 calnexin and the precursors of gB, gC, and gD of HSV-
1, we performed pulse – chase experiments withwere first synthesized with molecular masses of 128,
107, and 54 kDa, respectively, and after 6 hr of chase, shorter pulse and chase intervals. HSV-1-infected HEL
were pulsed with [35S]methionine for 10 min, and atthey became mature and their molecular masses in-
creased to 134, 130, and 61 kDa, respectively, mainly different chase times, the radiolabeled precursors of
gB, gC, and gD of HSV-1 coprecipitated with calnexinbecause of the addition of O-linked glycans as well as the
processing of N-linked oligosaccharides (27). In these were immunoisolated under nondenaturing conditions
and analyzed by SDS – 7.5% PAGE. In parallel, the la-immunoprecipitation experiments, we also noted that vi-
rus-specific proteins with molecular weights of 66 and beled cells were subjected to immunoprecipitation
with anti-gB, anti-gC, or ant-gD under denaturing con-51 kDa were precipitated with immune and control rabbit
sera. Judging from their apparent molecular size, these ditions and the profiles of maturation of the glycopro-
teins were also shown in the same gel (Fig. 4A). Asbands appear to be HSV-1 gE and gI, a complex of which
can act as a receptor for the Fc domain of immunoglobu- mentioned in Fig. 2, gB, gC, and gD of HSV-1 were first
synthesized as precursor proteins with lower molecu-lin G.
To confirm whether these proteins precipitated with lar masses on a SDS – polyacrylamide gel (128, 107,
and 54 kDa, respectively), and upon chase, they be-anticalnexin were the authentic precursors of gB, gC,
and gD of HSV-1, we designed sequential immunoprecip- came mature to have higher molecular masses (134,
130, and 61 kDa, respectively) when they were trans-itations as described in the legend to Fig. 3. Radiolabeled
HEL infected with HSV-1 for 12 hr were lysed and sub- ported from the endoplasmic reticulum (ER) to the
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of chase, nearly 25% of the molecule still remained to
be a precursor form.
Previous studies have shown that the partially trimmed
N-linked oligosaccharide side chain is a prerequisite for
glycoproteins to bind calnexin (8, 9, 26, 28, 29). Thus, we
next tested the effects of the glycosylation inhibitors, tuni-
camycin and castanospermine, on the association of the
precursor glycoproteins with calnexin. HSV-1-infected HEL
were pulsed with [35S]methionine for 20 min in the presence
of the inhibitors. The radiolabeled cells were subjected to
immunoprecipitaion with anticalnexin under nondenaturing
conditions or with anti-gB, anti-gC, or anti-gD under dena-
turing conditions and analyzed by SDS–7.5% PAGE. Figure
5A shows the SDS–PAGE profiles of tunicamycin-treated
HSV-1-infected cells. Since tunicamycin inhibits a mem-
brane-bound oligosaccharide transferase and thus pre-
FIG. 3. Identification of the proteins coprecipitated with calnexin in vents core glycosylation of nascent glycoprotein precursors
HSV-1-infected HEL. Confluent monolayers of HEL were infected with (30), the nascent glycoprotein precursors cannot acquire
HSV-1 for 12 hr. The cells were labeled for 20 min with [35S]methionine
N-linked oligosaccharides. So, in tunicamycin-treated cells,and subjected to first-round immunoprecipitation with anticalnexin (Cal)
the molecular mass of the glycoprotein precursors wereor normal rabbit serum (NS) under nondenaturing conditions. The im-
munoprecipitates were analyzed by SDS–7.5% PAGE (First IP, ND). For reduced by 9 kDa for gB, 19 or 23 kDa for gC, and 8
sequential immunoprecipitation, the Sepharose bead-bound antigens kDa for gD, respectively (Fig. 5A). At the concentration of
purified with first-round immunoprecipitation with anticalnexin under tunicamycin adopted in the experiments, the inhibition of
nondenaturing conditions were eluted by boiling in 200 ml of 50 mM
glycosylation was only partial, and along with the impairedTris–HCl (pH 7.4)–150 mM NaCl–2% SDS. After centrifugation, the
glycoprotein precursors, normally processed precursors ofsupernatant was diluted, divided into four equal aliquots, and subjected
to second-round immunoprecipitation with specific antibodies against gB, gC, and gD were also observed. In these cells, no
HSV-1 glycoproteins (gB, gC, and gD) or normal rabbit serum (NS). The precipitation of the glycoprotein precursors affected with
immunoprecipitates were analyzed by SDS–7.5% PAGE (Sequential IP, tunicamycin was detected, indicating that N-linked oligo-
Denaturing). For comparison, SDS–PAGE profiles of the precursors of
saccharide is important for the binding of these precursorsgB, gC, and gD of HSV-1 isolated from the HSV-1-infected HEL lysates
to calnexin. In castanospermine-treated HSV-1-infectedprocessed in parallel under denaturing conditions were also shown to
the right of the gel (First IP, Denat.). Molecular mass markers are shown cells, the glycoprotein precursors migrated slightly more
to the right of the gel (in kilodaltons). slowly than those in untreated cells (Fig. 5B). In these cells,
we could not detect any association between the gB, gC,
and gD precursors and calnexin. Castanospermine inhibits
Golgi beyond. So, it is not surprising that, for all the glucosidases I and II and thus prevents the trimming of
glycoproteins studied here, only the precursor forms three terminal glucoses from the core N-linked oligosac-
could bind to calnexin, since calnexin is an ER resident charides (31), resulting in a reduced amount of the mono-
protein (26). Although the precursors of gB, gC, and glucolylated form of N-linked oligosaccharides in the
gD of HSV-1 were found to associate with calnexin treated cells. Since calnexin is known to preferentially bind
from immediately after the pulse, the kinetics of associ- to the monoglucosylated form of N-linked oligosaccharides
ation significantly varied from one another (Fig. 4B). (26, 32), our observation was compatible with the previous
For the gC and gD precursors, maximum association findings that castanospermine inhibits the association of
was observed immediately after the pulse, and they calnexin with a variety of nascent glycoproteins (9, 10).
dissociated from calnexin rapidly, with a half-time of Calnexin, a recent identified integral membrane pro-
25 min for the gC precursor and 30 min for the gD tein in the ER, is thought to act as a chaperone in the
precursor, respectively. In contrast, for the gB precur- ER (8). It has a preferential binding activity to glycopro-
sor, maximum binding to calnexin did not appear im- teins and associates transiently with folding intermedi-
mediately after the pulse, but after 30 min of chase, ates of a wide variety of glycoproteins during normal
they showed prolonged association and dissociated processing but also binds to malfolded glycoproteins and
with a half-time of 70 min. For comparison, the kinetics retains them in the ER (29, 33, 34). In this report, we
of the processing rates with which the precursors of studied the role of calnexin during the processing of
gB, gC, and gD of HSV-1 were converted to the mature HSV-1 glycoproteins. As shown in Fig. 2, we could detect
form was also shown (Fig. 4C). Processing of gC and three HSV-1 proteins transiently associated with calnexin
gD was fast, and by 180 min of chase, most of the by pulse–chase experiments under nondenaturing con-
precursors were converted to the mature form. In con- ditions. Sequential immunoprecipitation clearly demon-
strated that these were the precursors of gB, gC, and gDtrast, processing of gB was quite slow, and at 480 min
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FIG. 4. The kinetics of association of the gB, gC, and gD precursors with calnexin. (A) HSV-1-infected HEL at 12 hr were labeled for 20 min with
[35S]methionine and chased for 0 to 360 min. The cells were lysed and subjected to immunoprecipitation with anticalnexin or normal rabbit serum
(NS) under nondenaturing conditions or with anti-gB, anti-gC, or anti-gD under denaturing conditions. The immunoprecipitates were analyzed by
SDS –7.5% PAGE. Molecular mass markers are also shown to the right of the gel (in kilodaltons). (B) HSV-1-infected HEL were labeled for 10 min
with [35S]methionine and chased for 0 to 480 min. The cells were lysed under nondenaturing conditions, and the lysates were immunoprecipitated
with anticalnexin. The precipitates were analyzed by SDS–7.5% PAGE, and the bands of the precursors for gB (open square), gC (open triangle),
and gD (open circle) coprecipitated with calnexin were quantitated with the Fujix Bio-Imaging Analyzer BAS2000 System. The incorporated radioactivity
at each time point was plotted as the percentage of the maximum coprecipitation found. (C) In parallel, the cells were lysed under denaturing
conditions, and the radiolabeled gB, gC, and gD were precipitated with specific antibodies. The precipitates were analyzed by SDS–7.5% PAGE,
and the bands of the mature gB (open square), gC (open triangle), and gD (open circle) were quantitated in the same way. The incorporated
radioactivity was plotted as the percentage of the total gB, gC, or gD at each time point.
of HSV-1 (Fig. 3). The association was observed at 12 hr ation between these molecules and calnexin did not re-
quire newly synthesized calnexin.after infection, when synthesis of calnexin was com-
pletely inhibited (Fig. 1B). In these cells, the amount of For most glycoproteins with which calnexin tran-
siently interacts as a chaperone, binding to calnexintotal cellular calnexin was almost unchanged compared
with that in mock-infected cells (Fig. 1A). These data seems to be restricted to a period of 0 to 60 min imme-
diately after chain termination, during which individualsuggest that the precursors of gB, gC, and gD of HSV-1
bound to preexisting calnexin, in other words, the associ- proteins acquire disulfide bonds and assemble into
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FIG. 5. Effects of inhibitors for N-linked oligosaccharide processing on the association of the gB, gC, and gD precursors with calnexin. HSV-1-
infected HEL were pretreated for 45 min with tunicamycin (TM; A) (10 mg/ml) or 1 mM castanospermine (CST; B), labeled for 20 min with [35S]methionine
in the continued presence of the inhibitor. The cells were lysed and subjected to immunoprecipitation with anticalnexin (Cal) or normal rabbit serum
(NS) under nondenaturing.
oligomeric complexes (9, 28, 29). However, the kinetics Thus, it may be reasonable that molecules which fold
slowly show prolonged association with calnexin,of association between the HSV-1 glycoproteins and
calnexin was quite different. For the precursors of gC since it has been shown that calnexin not only retains
folding intermediates in the ER but also protects themand gD, the association with calnexin was restricted
to a period early in the chase, as reported for other from degradation (33). Except for some malfolded mu-
tant glycoproteins, such a prolonged association withglycoproteins, including some viral glycoproteins. For
these precursors, the maximum binding to calnexin calnexin is rare and has only been reported for the
HCV envelope glycoproteins, E1 and E2 (36). For thesewas observed immediately after the pulse, and thereaf-
ter, they dissociated rapidly, with half-times of 25 min proteins, both E1 and the precursor of E2, E2-NS2,
rapidly associate with calnexin. However, their dissoci-for gC and 30 min for gD, respectively (Fig. 4B). In
contrast, the kinetics of association between the gB ation takes a long time, over 240 min, during which E1
acquires disulfide bonds slowly, E2-NS2 is endopro-precursor of HSV-1 and calnexin was different from
those and quite prolonged. The maximum association teolytically cleaved into E2, and finally, they oligo-
merize to form E1E2 complexes. As far as gB of HSV-was observed at 30 min after synthesis and thereafter
dissociation proceeded with a half-time of 70 min. At 1 is concerned, its processing was quite slow, and
at 480 min of chase, nearly 25% of the molecule still480 min of chase, a considerable amount of the gB
precursor of HSV-1 was still found associated with cal- remained to be a precursor form (Fig. 4C). Glycopro-
teins with a slow rate of processing may require pro-nexin (Fig. 4B). These observations suggest that there
is some relationship between the rate of processing longed association with calnexin to avoid misfolding
and resultant degradation in the ER.of these precursors to the mature forms and the kinet-
ics of calnexin association (Figs. 4B and 4C); that is, As shown in Figs. 5A and 5B, N-linked oligosaccha-
rides, especially the monoglucosylated form, seemedwhile the glycoproteins that are processed rapidly ,
such as gC and gD, rapidly associate with calnexin to be a prerequisite for the association of the precur-
sors of gB, gC, and gD of HSV-1 with calnexin. Whatand their association is quite short, those that take
much time to be processed to a mature form have is the role of N-linked sugar in the association between
them? Recently, Hammond et al. have proposed aprolonged association kinetics with calnexin. The ER
not only is the site at which newly synthesized proteins model of the quality control system for glycoproteins
in the ER (9, 28, 37). The model may give an answerfold correctly or assemble into requisite oligomeric
complexes but also functions as a clearinghouse to the question. According to the model, there is a
de- and reglucosylation cycle in the ER, composed ofthrough which misfolded or incorrectly assembled pro-
teins are destroyed to maintain homeostasis by the so- glucosidase II, UDP – glucose:glycoprotein glucosyl-
transferase, and calnexin. Here, the N-linked oligosac-called ‘‘ER degradation’’ pathway (35). Folding interme-
diates of proteins that fold and/or assemble slowly may charides serve as signals of a glycoprotein’s folding
status, and calnexin acts as a retention factor, whichbe exposed to such a degradation pathway for longer.
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